To this point, we showed that miR-126 OE and MMPi treatment suppressed tumor growth in CRC murine tumor models, partly by reducing HB-EGF-active proteases, impairing miR-221, and enhancing miR-126 expression. This evidence concerns the gene HBEGF and colorectal carcinoma.